ITM2B anticorps (N-Term)
Aperçu rapide pour ITM2B anticorps (N-Term) (ABIN113331)
Antigène
Voir toutes ITM2B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Affinity chromatography.
-
Immunogène
- Peptide coupled to carrier protein. Amino terminal sequence of BRI protein (ITM2B)
-
-
-
-
Indications d'application
-
Suitable for Western blot and not recommended for Immunohistochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Phosphate buffered saline, pH 7.2 with 0.09 % sodium azide as preservative.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody at 2-8 °C for one month or (following reconstitution in aliquots) at -20 °C for longer.
-
-
- ITM2B (Integral Membrane Protein 2B (ITM2B))
-
Autre désignation
- ITM2B
-
Sujet
- This antibody has been developed against the amino terminal sequence of BRI protein (ITM2B), a type-II single spanning transmembrane protein found in brain and other tissues. Mutation of the BRI gene with concomitant elongation of the carboxy terminus and its cleavage by the protease furin has been shown to lead to deposition of a protein fragment that may be involved in the pathogenesis of familial British dementia.Synonyms: BRI, BRI2, ITM2B, Integral membrane protein 2B, Transmembrane protein BRI
-
ID gène
- 9445
-
NCBI Accession
- NP_068839
-
UniProt
- Q9Y287
Antigène
-